Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 7OTHER_GOV 3NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Disease 1

Interventions

Capecitabine 9Bevacizumab 8tislelizumab 7Oxaliplatin 7Drug Therapy 7pembrolizumab 6Surgical Procedures, Operative 6Cisplatin 6Standard of Care 5Radiotherapy 5Laparoscopy 5Fluorouracil 5Docetaxel 5Carboplatin 5toripalimab 4Radiosurgery 4Leucovorin 4Exercise 4Epirubicin 4Cyclophosphamide 4pertuzumab 3durvalumab 3dalpiciclib 3atezolizumab 3anlotinib 3Saline Solution 3Rituximab 3Radiation 3Prednisone 3Population Groups 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Mammography × 1 year × Clear all
NCT06629896 2026-05-07

CEM

Azienda USL Reggio Emilia - IRCCS

Phase NA Recruiting
2,200 enrolled
Breast

Breast Neoplasms, Disease

NCT02698202 2025-12-19

Screening for Breast Cancer With Digital Breast Tomosynthesis

Azienda USL Reggio Emilia - IRCCS

Phase NA Completed
26,877 enrolled
Breast

Breast Neoplasms

NCT04461808 2025-06-25

MAITA

Azienda USL Reggio Emilia - IRCCS

Phase NA Active not recruiting
10,156 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡